Country Icon

PDL BioPharma, Inc. (PDLI) - Buy, Sell or Hold?

Sector: Health Care   Sub-Sector: Biotechnology: Biological Products (No Diagnostic Substances)
Trade DateCurrent Candlestick PatternPrevious Candlestick PatternWhenPerformance Since
Tue, 27 Jan 2015NoneBullish EngulfingMon, 26 Jan 20151.18%
***Stock database and scans are updated around midnight (New York time) every trading day.
7.64 -0.08 (-1.03%) Jan 28 10:52am EST
Open: 7.76 Range: 7.63 - 7.76 Vol: 373.47K Avg Vol: 2.64M
EPS: 1.97 P/E ratio: 3.87 EBITDA: 443.5M Mkt Cap: 1.240B
Analyze "PDLI" - FREE 30 Day Trial of Market Analyst 7
Short Term: Trend is Up
Last Trade is above the 5 day moving average at 7.60
Medium Term: Trading is Range Bound
Last Trade is above the 20 day moving average at 7.51
Last Trade is below the 50 day moving average at 7.70
Long Term: Trend is Down
Last Trade is below the 200 day moving average at 8.62
* Data normalized for Splits & Dividends. Report data issues
How to use this info: Stock Timing With Moving Averages
Daily Chart of PDLI

Stock Trend Analysis - Buy, Sell or Hold "PDL BioPharma, Inc." (PDLI)?

PDLI is trading below its 200 day moving average and objectively, many will consider the long term trend to be down. Care must however be taken with this view as in its last 52 week trading history, it is noted that PDLI has been range bound with a slight upward bias, having traded above the 200 SMA about 56% of the time. The medium term trend for PDLI is extremely bearish and weak, having traded almost 84% of the time below the 50 day moving average. The 20 day moving average is indicating range bound trading, also with a bearish bias. Objectively, as long as PDLI is trading below its 200 SMA, rallies will be sold into and traders can expect a lot of resistance near the 200 SMA currently at 8.62. Technically there are too many uncertainties to recommend a buy on this stock at this moment. Click here for the latest support & resistance levels to help you finetune your entry into or exit out of "PDLI".

The analyst consensus estimates for the 1 year price target for this stock is $8.00* (*source: Yahoo Finance).

Objective Technical Analysis by BannRonn TA LogicEngine ver 1.1. Last Updated - Tue, 27 Jan 2015
Health Care Stocks Above 200 Day Moving-Average
TickerNameTrend AnalysisSupport/Resistance
MYGNMyriad Genetics, Inc.Buy, Sell or HoldTrading Levels & Pivots
ISRGIntuitive Surgical, Inc.Buy, Sell or HoldTrading Levels & Pivots
ATRIATRION CorporationBuy, Sell or HoldTrading Levels & Pivots
ATRCAtriCure, Inc.Buy, Sell or HoldTrading Levels & Pivots
HUMHumana Inc.Buy, Sell or HoldTrading Levels & Pivots
DRADDigirad CorporationBuy, Sell or HoldTrading Levels & Pivots
LHLaboratory Corporation of America HoldingsBuy, Sell or HoldTrading Levels & Pivots
ZIOPZIOPHARM Oncology IncBuy, Sell or HoldTrading Levels & Pivots
QDELQuidel CorporationBuy, Sell or HoldTrading Levels & Pivots
STESTERIS CorporationBuy, Sell or HoldTrading Levels & Pivots